Q2 2026 Holdings
Filed 2026-08-14 | 104 holdings | $2.0B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $207.0M | 1,105,210 | 10.1% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $123.8M | 2,179,069 | 6.0% |
| ELI Lilly & Co(LLY) | COM | 532457108 | $118.4M | 98,700 | 5.8% |
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $94.0M | 174,999 | 4.6% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $93.4M | 798,145 | 4.6% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $76.9M | 692,598 | 3.8% |
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $52.0M | 453,156 | 2.5% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $48.9M | 52,750 | 2.4% |
| Ascendis Pharma A/S(ASND) | ORD SHS | K08588103 | $45.0M | 168,750 | 2.2% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $41.3M | 683,907 | 2.0% |
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $39.3M | 715,452 | 1.9% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $38.6M | 362,150 | 1.9% |
| Penumbra Inc(PEN) | COM | 70975L107 | $36.5M | 115,750 | 1.8% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $34.4M | 640,317 | 1.7% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $32.3M | 967,855 | 1.6% |
| Irhythm Holdings Inc(IRTC) | COM | 450056106 | $32.1M | 269,650 | 1.6% |
| Intuitive Surgical Inc(ISRG) | COM NEW | 46120E602 | $30.4M | 76,460 | 1.5% |
| Agilon Health Inc(AGL) | COM NEW | 00857U206 | $28.1M | 262,600 | 1.4% |
| Unitedhealth Group Inc(UNH) | COM | 91324P102 | $26.5M | 63,750 | 1.3% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $26.0M | 699,146 | 1.3% |
| Erasca Inc(ERAS) | COM | 29479A108 | $25.7M | 1,402,150 | 1.3% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $24.4M | 144,750 | 1.2% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $23.6M | 464,625 | 1.2% |
| Tenet Healthcare Corp(THC) | COM NEW | 88033G407 | $23.4M | 125,000 | 1.1% |
| Dexcom Inc(DXCM) | COM | 252131107 | $23.1M | 343,000 | 1.1% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $22.9M | 4,330,532 | 1.1% |
| Minimed Group Inc(MMED) | COM | 60365F109 | $22.7M | 1,520,000 | 1.1% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $22.6M | 528,500 | 1.1% |
| Pharvaris N V(PHVS) | COM | N69605108 | $22.4M | 648,333 | 1.1% |
| Avalyn Pharmaceuticals Inc(AVLN) | COM SHS | 05348Y105 | $21.8M | 662,918 | 1.1% |
| Hemab Therapeutics Hldgs Inc(COAG) | COM SHS | 423494103 | $21.1M | 575,432 | 1.0% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $20.9M | 942,154 | 1.0% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $20.1M | 66,750 | 1.0% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $20.0M | 515,917 | 1.0% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $19.8M | 532,563 | 1.0% |
| Newamsterdam Pharma Company(NAMS) | ORDINARY SHARES | N62509109 | $19.7M | 582,744 | 1.0% |
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $18.3M | 427,584 | 0.9% |
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $17.4M | 277,087 | 0.9% |
| Heartflow Inc(HTFL) | COM | 42238D107 | $16.8M | 573,500 | 0.8% |
| MBX Biosciences Inc(MBX) | COM | 55287L101 | $16.5M | 298,218 | 0.8% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $16.0M | 187,980 | 0.8% |
| Bicara Therapeutics Inc(BCAX) | COM | 055477103 | $15.9M | 535,286 | 0.8% |
| Parabilis Medicines Inc(PBLS) | COM | 698955101 | $15.8M | 578,028 | 0.8% |
| ZAI LAB LTD(ZLAB) | ADR | 98887Q104 | $15.5M | 814,707 | 0.8% |
| Danaher Corp del(DHR) | COM | 235851102 | $14.5M | 76,300 | 0.7% |
| Tango Therapeutics Inc(TNGX) | COM | 87583X109 | $14.3M | 456,551 | 0.7% |
| Evolent Health Inc(EVH) | CL A | 30050B101 | $13.6M | 2,500,000 | 0.7% |
| PTC Therapeutics Inc(PTCT) | COM | 69366J200 | $13.2M | 162,298 | 0.6% |
| Mineralys Therapeutics Inc(MLYS) | COM | 603170101 | $13.1M | 484,951 | 0.6% |
| Zenas Biopharma Inc(ZBIO) | COM | 98937L105 | $12.7M | 502,077 | 0.6% |